Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
Rappta Therapeutics has raised €9.0M across 1 funding round from 2 investors, most recently a Series A round in Oct 2020. Based in Helsinki, Finland; founded 2006; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-13 | Series A |
| €9.0M |
| Novartis Venture Fund,Novo Holdings |
| View deal → |
